Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 2.72 g/t Au over 139.9 metres at Golden Summit (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Whoever
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1022)
•••
Comment by Nailbiter2on Dec 22, 2022 6:12pm
175 Views
Post# 35188237

RE:RE:RE:Whoever

RE:RE:RE:Whoever
Liked2Think wrote:
Nailbiter2 wrote: You do know what the purpose of tax loss selling is right?
To cut down on taxes owing from your monster investments.
Where do you see monsters that need trimming?

Look these two pandemic racers, Netflix and Amazon for example.
They are now hovering in the triple "S" range.

Wish You Merry Christmas




You do know its for the entire year and not just the last part right?

I did quite well on one of my investments.  Not nearly enough to recover the massive amount I lost on this stinker but it helped.

If you dont think alot of people still made money in the market this year then you are crazy and this is just another lame pumper excuse.

Not a pump excuse, just another lame bash snivel.

You made my point buddy boy.

Not a single stock in 2022 is in need of being hobbled
to merit selling this one at a loss.
This is a stick-'n-see year.

Not even Roarin' Rory is dropping to ease his painful gains.

If he does, I'll write your name on a dingy old jock stap of mine and
youtube myself eating it in your honor.
STG...

Hair In Mouth GIFs | Tenor
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities